Seifert J, Buchar E
Chem Biol Interact. 1981 May;35(2):217-28. doi: 10.1016/0009-2797(81)90145-9.
Following the administration of D-galactosamine the utilization of [2-14C] orotic acid for the synthesis of the cytidine components of the acid-soluble extract and liver RNA cytosine is markedly decreased. The depression of the specific activity of the cytidine components takes place after application of low doses of the drug which do not interfere with the specific activity of the uridine components of the acid-soluble extract or of liver RNA uracil. Simultaneously the administration of [U-14C]cytidine paralleled by its enhanced liver uptake. The total amount of uridine as well as cytidine components of the acid-soluble extract following the administration of D-galactosamine increases; however, the molar ratio of both pyrimidines does not change. The alterations of the cytidine metabolism after the administration of the drug are accompanied by the increased level of microsomal cytochrome P-450.
给予D-半乳糖胺后,用于合成酸溶性提取物和肝脏RNA胞嘧啶的胞苷成分的[2-¹⁴C]乳清酸利用率显著降低。在应用低剂量药物后,胞苷成分的比活性降低,而这些低剂量药物并不干扰酸溶性提取物或肝脏RNA尿嘧啶的尿苷成分的比活性。同时,[U-¹⁴C]胞苷的给药伴随着其肝脏摄取的增加。给予D-半乳糖胺后,酸溶性提取物中尿苷和胞苷成分的总量增加;然而,两种嘧啶的摩尔比没有变化。给药后胞苷代谢的改变伴随着微粒体细胞色素P-450水平的升高。